Lebwohl MG, et al. Dermatol Ther (Heidelb). 2026;16(10):5049-5068.
Safety of Icotrokinra Through 1 Year for the Treatment of Moderate-to-Severe Plaque Psoriasis and Psoriasis Affecting High-Impact Sites
calendar_today
October 12, 2026
domain
protagonist-therapeutics